I’m seeking insights from U.S.-based primary care physicians (family medicine, internal medicine, or general practice) who are currently in practice. I’d like to know how you are implementing the AHA’s Life’s Essential 8 cardiovascular health metrics in real-world primary care — what’s working, what challenges you face, and how these guidelines fit into your daily clinical workflow.
How have you integrated Life’s Essential 8 into routine primary care visits, and what strategies have worked best in actually measuring or counseling on these metrics?
What are the biggest barriers you face in applying Life’s Essential 8 in a busy clinic setting — whether time, reimbursement, patient engagement, or something else?
Which of the 8 metrics do you find most difficult to address with patients, and how do you approach those conversations?
Have you found ways to involve other care team members (nurses, health coaches, pharmacists, etc.) in supporting patients with these metrics, and if so, what’s been effective?
From your perspective, has emphasizing Life’s Essential 8 made a measurable difference in your patients’ cardiovascular health, and what advice would you give other PCPs trying to put this into practice?
By responding, you consent to being quoted with full name, title, and affiliation, allow light editing of your responses, and confirm disclosure of any conflicts of interest.
posted9/9/2025
deadline9/12/2025
processing
published
Recently published by Medscape
Looking to speak with Ob-Gyns, Maternal-Fetal and primary care experts
Seeking U.S.-based experts in pulmonology to comment on innovations in COPD and asthma care
I am working on a Medscape article about new approaches to managing COPD and asthma that go beyond standard inhaler therapy. I am seeking U.S.-based pulmonologists, researchers, or physicians with experience in pulmonary medicine to share insights on emerging strategies in clinical practice and research.
Questions:
What innovations in COPD and asthma care are you seeing beyond pharmacotherapy (e.g., breathing techniques, pulmonary rehab, personalized approaches)?
Are you using or researching personalized oxygen protocols? If so, how do they compare with standard oxygen therapy?
What role do biologic or precision-medicine therapies play in COPD and asthma management today?
What barriers exist in implementing these newer approaches (cost, access, adherence)?
How can primary care providers best incorporate or refer for these innovations?
Looking ahead, what developments are most promising for improving COPD and asthma outcomes over the next 5 years?
Consent Note:
By responding, you consent to being quoted in a Medscape article with attribution. Quotes may be lightly edited for clarity, style, and flow. Please disclose any potential conflicts of interest (such as financial relationships with relevant companies or organizations).